PALANTIR TECHNOLOGIES, INC. for PALANTIR TECHNOLOGIES INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY24 Department of Homeland Security (DHS) appropriations; FY24 Financial Services and General Government appropriations - funding for Office of National Drug Control Policy (ONDCP)/High Intensity Drug Trafficking Areas (HIDTA); FY24 Department of Health and Human Services (HHS) appropriations - funding for healthcare programs, including funding for Food and Drug Administration, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform; FY24 Agriculture, Rural Development, Food and Drug Administration appropriations, including 21 Forward Program at FDA
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA (MANDI) L. MILLER | — |
Government Issues GOV
IT acquisition reform; Broader commercial item preference; Deployment of the Palantir Government software platform in defense and civilian organizations; Federal Aviation Administration (FAA) Reauthorization Act; Pandemic All-Hazards Preparedness Act reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMANDA (MANDI) L. MILLER | — |
Defense DEF
H.R 2670, the National Defense Authorization Act of 2024; S. 2226, the National Defense Authorization Act of 2024; Department of Defense Appropriations Bill of 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| ABBEY OVERLAND | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.